Am J Health Syst Pharm. 2006;63(19):1806-1809. This installment of the Medicare Modernization Act (MMA) Q&A describes pharmacists' use of a Web-based program to document and be reimbursed for ...

Key Points - GLP-1 agonists have ushered in a new era in anti-obesity medication policy considerations against the backdrop of a continued focus by policymakers on both drug access and pricing.